Exploring NEXGEL, Inc. (NXGL) Investor Profile: Who’s Buying and Why?

Exploring NEXGEL, Inc. (NXGL) Investor Profile: Who’s Buying and Why?

US | Healthcare | Medical - Instruments & Supplies | NASDAQ

NEXGEL, Inc. (NXGL) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Ever wondered who's investing in NEXGEL, Inc. (NXGL) and what's driving their interest? With 24 institutional owners holding a total of 520,895 shares, and retail investors accounting for 37.7% of total ownership, the investor landscape is indeed complex. Is it the company's impressive 112% revenue increase in 2024, reaching $8.69 million, or the strategic product expansions and partnerships that have captured their attention? Perhaps the surge in Q4 2024 revenue to $3.04 million, a staggering 181% year-over-year increase, has something to do with it? Dive in to uncover the key players and the factors influencing their investment decisions, from major shareholders like Renaissance Technologies Llc and Morgan Stanley to the blend of institutional, retail, and individual investors shaping the company's trajectory.

NEXGEL, Inc. (NXGL) Who Invests in NEXGEL, Inc. (NXGL) and Why?

Understanding the investor profile of NEXGEL, Inc. (NXGL) involves examining the types of investors who are putting their capital into the company, their motivations for doing so, and the investment strategies they employ. This provides valuable insights into the market's perception of NEXGEL, Inc. (NXGL) and its future prospects. Here's an exploration into who is investing in NEXGEL, Inc. (NXGL) and the underlying reasons.

Key Investor Types:

The investor base of NEXGEL, Inc. (NXGL) can be categorized into several key types:

  • Retail Investors: These individual investors buy or sell securities for their own personal accounts, and their investment decisions are typically driven by factors such as personal financial goals, risk tolerance, and investment knowledge.
  • Institutional Investors: These are entities that pool large sums of money and invest in securities, real property, and other investment assets. They include investment banks, insurance companies, pension funds, hedge funds, and mutual funds.
  • Hedge Funds: These are investment partnerships that use pooled funds and employ different strategies to earn active return, or alpha, for their investors. Hedge funds may invest in a variety of assets, including stocks, bonds, and derivatives.

Investment Motivations:

Several factors might attract investors to NEXGEL, Inc. (NXGL):

  • Growth Prospects: Investors may be drawn to NEXGEL, Inc. (NXGL) if they believe the company has strong growth potential in its respective markets. This could be due to innovative products, expanding market share, or favorable industry trends.
  • Market Position: The company's standing in its industry, its competitive advantages, and its brand reputation can all influence investor interest. A strong market position may suggest stability and long-term value.

Investment Strategies:

The strategies employed by investors in NEXGEL, Inc. (NXGL) can vary widely:

  • Long-Term Holding: Some investors may adopt a buy-and-hold strategy, intending to hold their shares for an extended period, often several years or more. These investors typically believe in the company's long-term potential and are willing to ride out short-term market fluctuations.
  • Short-Term Trading: Other investors may engage in short-term trading, seeking to profit from short-term price movements. These traders may use technical analysis and other tools to identify trading opportunities and may hold their positions for only a few days or weeks.
  • Value Investing: Value investors look for companies that they believe are undervalued by the market. They may be attracted to NEXGEL, Inc. (NXGL) if they believe the company's stock price is below its intrinsic value, based on factors such as its assets, earnings, and growth potential.

Understanding the motivations and strategies of these diverse investor groups is crucial for NEXGEL, Inc. (NXGL) to effectively communicate its value proposition and manage investor relations. For further insights into the company's guiding principles, explore Mission Statement, Vision, & Core Values of NEXGEL, Inc. (NXGL).

NEXGEL, Inc. (NXGL) Institutional Ownership and Major Shareholders of NEXGEL, Inc. (NXGL)

Institutional ownership in NEXGEL, Inc. (NXGL) provides insights into the stability and investor confidence in the company. Examining the major institutional investors, changes in their holdings, and the overall impact they have can offer a clearer understanding of the stock's potential and the company's strategic direction.

Unfortunately, as of my knowledge cut-off in April 2025, I don't have specific real-time data regarding the top institutional investors and their current shareholdings in NEXGEL, Inc. (NXGL). However, such information is typically available from financial data providers like:

  • Bloomberg
  • Reuters
  • Yahoo Finance
  • SEC Filings (specifically 13F filings)

These sources provide updated information on institutional ownership, reflecting the most current investment positions.

To get a sense of who these investors might be and the scale of their investment, you would generally look for filings and reports that detail:

  • The names of institutional holders
  • The number of shares held
  • The percentage of total shares outstanding represented by those holdings

Changes in institutional ownership can be a telling sign. Increases in holdings may suggest growing confidence in NEXGEL, Inc. (NXGL)’s prospects, while decreases might indicate concerns or shifts in investment strategy. Monitoring these changes over time can provide insights into the sentiment surrounding the stock.

The presence of large institutional investors can significantly influence NEXGEL, Inc. (NXGL)’s stock price. Their trading activity, given the large volumes they often deal in, can create upward or downward pressure. Moreover, institutional investors often engage with company management, influencing corporate strategy and governance.

For more details on NEXGEL, Inc. (NXGL)'s background, you might find this resource helpful: NEXGEL, Inc. (NXGL): History, Ownership, Mission, How It Works & Makes Money

To illustrate the kind of information that would be relevant, consider the hypothetical table below. Please note that this is purely for illustrative purposes and does not reflect actual data for NEXGEL, Inc. (NXGL).

Investor Shares Held (as of 2024) Percentage of Total Shares Outstanding
Hypothetical Fund A 500,000 2.5%
Hypothetical Investment Firm B 350,000 1.75%
Hypothetical Group C 200,000 1.0%

If you want to analyze the impact of institutional investors on NEXGEL, Inc. (NXGL), focus on:

  • Trading Volumes: High trading volumes associated with institutional activity can drive short-term price movements.
  • Long-Term Strategy: Significant institutional ownership can encourage a longer-term strategic view, aligning management’s interests with those of major shareholders.
  • Corporate Governance: Institutional investors often push for better governance practices and greater accountability.

Keep an eye on SEC filings and financial news outlets for the most current details on who is invested in NEXGEL, Inc. (NXGL) and how their investment strategies might be shaping the company’s trajectory.

NEXGEL, Inc. (NXGL) Key Investors and Their Impact on NEXGEL, Inc. (NXGL)

Understanding the investor profile of NEXGEL, Inc. (NXGL) provides critical insights into the company's stability, growth potential, and strategic direction. Key investors can significantly influence company decisions and stock performance through their holdings and actions.

While specific details on all major investors and their recent moves may not always be publicly available in real-time, examining publicly accessible filings and reports can shed light on the general investor landscape. Institutional investors, venture capital firms, and strategic corporate partners often play significant roles in the trajectory of companies like NEXGEL, Inc. (NXGL).

The influence of these investors can manifest in several ways:

  • Strategic Guidance: Major investors often have board representation, allowing them to influence strategic decisions, such as mergers, acquisitions, and significant operational changes.
  • Financial Stability: Large investments can provide financial stability, enabling NEXGEL, Inc. (NXGL) to fund research and development, expand operations, and weather economic downturns.
  • Market Confidence: The presence of well-known and respected investors can boost market confidence, attracting additional investment and positively impacting the stock price.
  • Activism: In some cases, activist investors may take significant stakes in a company to push for specific changes, such as improved corporate governance, cost-cutting measures, or strategic realignments.

Keeping track of investor moves, such as increases or decreases in their positions, can provide valuable signals about the company's prospects. For example, a large institutional investor increasing its stake might indicate confidence in NEXGEL, Inc. (NXGL)'s future performance, while a significant sell-off could raise concerns.

For more in-depth analysis of NEXGEL, Inc. (NXGL)'s financial standing, consider exploring Breaking Down NEXGEL, Inc. (NXGL) Financial Health: Key Insights for Investors.

NEXGEL, Inc. (NXGL) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions is crucial for evaluating the potential of any publicly traded company. For NEXGEL, Inc. (NXGL), several factors influence how investors perceive the company and how the stock market responds to key events.

As of March 27, 2025, NEXGEL, Inc. had over 1,047 shareholders of record with 7,654,037 shares of common stock outstanding. The company's common stock is traded on the NASDAQ Capital Market under the symbol 'NXGL'. Certain warrants to purchase common stock, issued on December 27, 2021, also trade on NASDAQ under the symbol 'NXGLW.'

Investor Sentiment:

Institutional ownership in NEXGEL, Inc. shows current positions held by institutions and funds, along with recent changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions.

According to Fintel, NEXGEL, Inc. (US:NXGL) has 24 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 520,895 shares. Largest shareholders include:

  • Renaissance Technologies Llc
  • Morgan Stanley
  • Geode Capital Management, Llc
  • Vanguard Group Inc
  • Simon Quick Advisors, Llc
  • FSMAX - Fidelity Extended Market Index Fund
  • VEXMX - Vanguard Extended Market Index Fund Investor Shares
  • VTSMX - Vanguard Total Stock Market Index Fund Investor Shares
  • GWM Advisors LLC
  • State Street Corp

According to MarketBeat, during the previous two years, the following institutional investors and hedge funds held shares of NEXGEL shares:

  • Renaissance Technologies LLC ($706K)
  • Geode Capital Management LLC ($268K)
  • Northeast Financial Group Inc. ($82K)
  • Two Sigma Securities LLC ($54K)
  • IFP Advisors Inc ($49K)
  • Virtu Financial LLC ($48K)

Notably, 2.21% of NEXGEL stock is owned by institutional investors. In the last 24 months, institutional investors have bought a total of 198,847 shares, representing approximately $828.76K in transactions.

The Fund Sentiment Score identifies stocks being heavily bought by funds, utilizing a quantitative model that considers the increase in disclosed owners, changes in portfolio allocations, and other metrics. The score ranges from 0 to 100, with higher numbers indicating greater accumulation; 50 is the average.

Recent Market Reactions:

The share price as of April 4, 2025, was $2.57 per share. Previously, on April 8, 2024, the share price was $2.19 per share, marking a 17.35% increase over that period.

Based on 14-day Average True Range, the stock is expected to open at $2.84 on Monday, April 21, 2025, and fluctuate between $2.61 and $3.05 during the day, indicating a possible trading interval of +/-$0.224 (+/-7.91%) from the last closing price.

Analyst Perspectives:

The average one-year price target for NEXGEL (NasdaqCM:NXGL) has been revised to $7.14 per share, a 16.67% increase from the prior estimate of $6.12 dated January 16, 2024. The latest targets range from a low of $7.07 to a high of $7.35 per share.

Analysts' recommendations provide insights into the potential direction and performance of a stock over 12 months. Ratings typically include:

  • Buy/Overweight/Outperform: Indicates the stock is likely to outperform a market index.
  • Hold/Equal-Weight/Market Perform: Suggests the stock will perform in line with a market index.
  • Sell/Underweight/Underperform: Suggests the stock is likely to underperform a market index.

As of February 23, 2024, analyst consensus showed:

  • Buy: 40%
  • Hold: 50%
  • Sell: 10%

NEXGEL is focusing on contract manufacturing, consumer products, and medical device development to drive growth. New product launches in 2025 include a SilverSeal wound kit and beauty under-eye patches. The company anticipates achieving positive cash flow from operations during 2025.

See more about NEXGEL, Inc. (NXGL) Financial Health: Breaking Down NEXGEL, Inc. (NXGL) Financial Health: Key Insights for Investors

DCF model

NEXGEL, Inc. (NXGL) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.